kratomjournalist

Will Florida’s 7-OH Ban Set Off a Domino Effect?

Florida Attorney General James Uthmeier has filed an emergency rule that classifies 7-hydroxymitragynine (7-OH) a Schedule I substance in Florida. “Due to the danger posed to the public, Florida is taking 7-OH off the shelves immediately,” said Uthmeier in a news release. “We are here today because Dr. Marty Makary and the FDA have alerted …

Will Florida’s 7-OH Ban Set Off a Domino Effect? Read More »

Could Kratom Consumers Catch DUI if 7-OH is Banned?

The alkaloid 7-hydroxymitragynine (7-OH) is unique in that it occurs mostly as a metabolite of mitragynine (MG), the most abundant alkaloid in kratom. On July 29, the Food and Drug Administration (FDA) announced its intention to recommend scheduling of 7-OH on the list of federally controlled substances, but explicitly stated that its not going after …

Could Kratom Consumers Catch DUI if 7-OH is Banned? Read More »

Wave of Negative News Engulfs Kratom Since FDA Move to Schedule 7-OH

A wave of negative media coverage (more than usual) has engulfed kratom in the weeks following the FDA’s July 29 recommendation to classify 7-hydroxymitragynine (7-OH) as an illicit substance. While the agency’s move targets products containing an abundance of 7-OH—not the plain leaf kratom that contains near-zero amounts of 7-OH—news outlets have blurred the distinction, …

Wave of Negative News Engulfs Kratom Since FDA Move to Schedule 7-OH Read More »

Multiple Kratom Ban Bills Sit in Massachusetts Legislature

This past spring, state lawmakers have filed six bills in Massachusetts having to do with kratom policy. Four of the bills aim to schedule kratom as a “Class A” controlled substance, which would put it in the same category as heroin and fentanyl. One bill, S1558, aims to regulate kratom similar to Kratom Consumer Protection …

Multiple Kratom Ban Bills Sit in Massachusetts Legislature Read More »

FDA Announces Plans to Schedule 7-OH as a Controlled Substance a Week After Kratom Industry Allegedly Staged 7-OH Protests

On Tuesday, July 29, officials including Department of Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr. and Food and Drug Administration (FDA) Commissioner Marty Makary announced via a press conference the FDA’s intent to recommend to the Drug Enforcement Administration (DEA) that 7-hydroxymitragynine (7-OH) be scheduled as a controlled substance. Several times during …

FDA Announces Plans to Schedule 7-OH as a Controlled Substance a Week After Kratom Industry Allegedly Staged 7-OH Protests Read More »

Dr. McCurdy at Kratom Debate: Natural Leaf is “the only product that should be in the marketplace”

The kratom industry is railing against 7-OH products as problematic, but are extra-strength kratom extracts problematic too? The controversy surrounding the rise of new 7-hydroxymitragynine (7-OH) products has sparked a debate among various players in the kratom industry, as well as scientists and consumers. A debate called “The 7-OH Fault Line” took place at the …

Dr. McCurdy at Kratom Debate: Natural Leaf is “the only product that should be in the marketplace” Read More »

AKA and HART Face Off Over 7-Hydroxymitragynine This Friday

Members of the American Kratom Association (AKA) and the Holistic Alternative Recovery Trust (HART) will debate the controversial alkaloid 7-hydroxymitragynine (7-OH) and the 7-OH-abundant products that have become available to consumers in the past 2 years. Billed as “The 7-OH Fault Line”, the debate will take place at the Las Vegas Convention Center 3150 Paradise …

AKA and HART Face Off Over 7-Hydroxymitragynine This Friday Read More »

Preliminary in silico Study Explores Kratom Alkaloids’ Effects on Breast Cancer Protein

Disclaimer: Kratom Is Not a Breast Cancer Treatment: While this study investigates the potential of kratom compounds mitragynine and 7-hyroxymitragynine to bind with HER2 receptors through computer modeling, it does not prove or suggest that kratom cures breast cancer. These results are preliminary and based solely on in silico simulations (i.e., computer-generated predictions). No clinical …

Preliminary in silico Study Explores Kratom Alkaloids’ Effects on Breast Cancer Protein Read More »

Germany Issues Health Warning on Kratom, Fuels Ban Speculation

Germany’s Federal Institute for Drugs and Medical Devices (BfArM) issued a warning in early July about the potential harms of kratom, sparking new concerns that a kratom ban might be forthcoming. “Kratom is not approved as a medicine in Germany. The safety and effectiveness of kratom have not been sufficiently tested so far,” reads a …

Germany Issues Health Warning on Kratom, Fuels Ban Speculation Read More »